Novo-aktien stiger kraftigt efter sløve salgsdata fra konkurrent
Eli Lilly halter bagefter Novo Nordisk på markedet for vægttabsmedicin i pilleform, siger analytiker.
Original Source
Read the full article at Politiken →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.